Neuronetics Inc. (STIM)
Neuronetics Statistics
Share Statistics
Neuronetics has 65.81M shares outstanding. The number of shares has increased by 119.4% in one year.
| Shares Outstanding | 65.81M |
| Shares Change (YoY) | 119.4% |
| Shares Change (QoQ) | 105.23% |
| Owned by Institutions (%) | 24.95% |
| Shares Floating | 36.92M |
| Failed to Deliver (FTD) Shares | 9.44K |
| FTD / Avg. Volume | 0.64% |
Short Selling Information
The latest short interest is 3.44M, so 5.4% of the outstanding shares have been sold short.
| Short Interest | 3.44M |
| Short % of Shares Out | 5.4% |
| Short % of Float | 5.57% |
| Short Ratio (days to cover) | 3.06 |
Valuation Ratios
The PE ratio is -1.16 and the forward PE ratio is -18.98. Neuronetics's PEG ratio is -0.04.
| PE Ratio | -1.16 |
| Forward PE | -18.98 |
| PS Ratio | 0.68 |
| Forward PS | 1.4 |
| PB Ratio | 1.84 |
| P/FCF Ratio | -1.57 |
| PEG Ratio | -0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Neuronetics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.86 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | -0.78 |
| Debt / FCF | -0.85 |
| Interest Coverage | -4.74 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $104.59K |
| Profits Per Employee | $-61.04K |
| Employee Count | 716 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 4.88 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 27.71% in the last 52 weeks. The beta is 1.98, so Neuronetics's price volatility has been higher than the market average.
| Beta | 1.98 |
| 52-Week Price Change | 27.71% |
| 50-Day Moving Average | 4.29 |
| 200-Day Moving Average | 2.19 |
| Relative Strength Index (RSI) | 59.34 |
| Average Volume (20 Days) | 1.47M |
Income Statement
In the last 12 months, Neuronetics had revenue of 74.89M and earned -43.71M in profits. Earnings per share was -1.38.
| Revenue | 74.89M |
| Gross Profit | 54.16M |
| Operating Income | -34.56M |
| Net Income | -43.71M |
| EBITDA | -35.17M |
| EBIT | -37.24M |
| Earnings Per Share (EPS) | -1.38 |
Balance Sheet
The company has 18.46M in cash and 27.48M in debt, giving a net cash position of -9.02M.
| Cash & Cash Equivalents | 18.46M |
| Total Debt | 27.48M |
| Net Cash | -9.02M |
| Retained Earnings | -419.79M |
| Total Assets | 133.45M |
| Working Capital | 26.63M |
Cash Flow
In the last 12 months, operating cash flow was -31M and capital expenditures -1.47M, giving a free cash flow of -32.46M.
| Operating Cash Flow | -31M |
| Capital Expenditures | -1.47M |
| Free Cash Flow | -32.46M |
| FCF Per Share | -1.03 |
Margins
Gross margin is 72.32%, with operating and profit margins of -46.15% and -58.36%.
| Gross Margin | 72.32% |
| Operating Margin | -46.15% |
| Pretax Margin | -58.41% |
| Profit Margin | -58.36% |
| EBITDA Margin | -46.96% |
| EBIT Margin | -46.15% |
| FCF Margin | -43.35% |
Dividends & Yields
STIM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for STIM is $7, which is 56.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 56.6% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -2.94 |
| Piotroski F-Score | 3 |